Institution
Stichting Epilepsie Instellingen Nederland
NLhealthcare
Recent research
- Biology
Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
BACKGROUND: Narcolepsy type 1 is characterized by excessive daytime sleepiness, cataplexy, disrupted sleep, sleep paralysis, and hypnagogic or hypnopompic hallucinations. Oveporexton (TAK-861), an oral orexin receptor 2-selective agonist, reduced symptoms of narcolepsy type 1 in...
- Health & MedicineOpen access
Abstract Background Large language models (LLMs) show promise for automating literature screening, although their performance varies across clinical domains and further evaluation is required for broader implementation. This study aimed to assess the accuracy, reliability and fea...